• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Cangene Corp

CNJ:CN

Acquired

Cangene Corp (CNJ:CN) was acquired by EBS:US


Company Profile

Cangene Corporation develops, manufactures, and sells biopharmaceutical drugs. The Company produces plasma-derived and recombinant therapeutic proteins used in the prevention of Rh disease and blood clotting deficiencies.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...
Advertisement
sec ||= nil